19 results on '"Grayson, Peter C."'
Search Results
2. Spectrum of clonal hematopoiesis in VEXAS syndrome
3. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis
4. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2
5. Clonal Hematopoiesis in a Broad Age Spectrum of Systemic Vasculitis
6. Eosinophilia in Vexas Syndrome: Expanding Hematologic Phenotype
7. DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways
8. Clonal Hematopoiesis in Vexas Syndrome
9. Thrombotic Manifestations in Patients with Vexas Syndrome
10. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
11. Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study
12. VEXAS Syndrome
13. Myelodysplasia and Bone Marrow Manifestations of Somatic UBA1 Mutated Autoinflammatory Disease
14. Somatic Mutations in a Single Residue of UBA1 Cause Vexas, a Severe Adult-Onset Rheumatic Disease Associated with Myeloid Dysplasia
15. Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study
16. Clinical Manifestations Are Evolving and Progressive in Patients with Vexas Syndrome
17. DNMT3A/TET2Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1and MPLOncogenic Pathways
18. Myelodysplasia and Bone Marrow Manifestations of Somatic UBA1Mutated Autoinflammatory Disease
19. Somatic Mutations in a Single Residue of UBA1Cause Vexas, a Severe Adult-Onset Rheumatic Disease Associated with Myeloid Dysplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.